Pibutidine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171953This classification denotes a histamine-2 receptor antagonist with the molecular formula C19H24N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4XRL9PL02Y, chemically known as 3-cyclobutene-1,2-dione, 3-amino-4-((4-((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)amino)-, (z)- but generally known as pibutidine, which bears US NIH Compound Identifier 5282450. European Medicines Agency schedules Pibutidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09805MIG. The term PIBUTIDINE is an International Non-Proprietary Name. PIBUTIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pibutidine under HS 29333999 and SITC 51574. As of Q4 2014, PIBUTIDINE remains the US FDA Preferred Term for this commodity. Pibutidine bears US NLM identifiers UMLS ID C2825480 and NCI Concept Code C81156. SMILES: O(C1NCCC(CN2CCCCC2)C1)C/C=C\CNC1=C(N)C(=O)C1=O.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.